No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Thursday, October 30, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs

by TheAdviserMagazine
3 weeks ago
in Business
Reading Time: 3 mins read
A A
This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs
Share on FacebookShare on TwitterShare on LInkedIn


Insmed (INSM) is a biopharmaceutical company with strong momentum.

Shares are trading at new 20-year highs.

INSM has surged 128% over the past year.

Analysts expect robust revenue and earnings growth, but opinions are mixed, with some cautioning the stock is overvalued.

Valued at $34.3 billion, Insmed (INSM) is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, a treatment for rare lung conditions.

Insmed is also focused on the development of INS1009, an inhaled treatment for pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.

I found today’s Chart of the Day by using Barchart’s powerful screening functions to sort for stocks with the highest technical buy signals; superior current momentum in both strength and direction; and a Trend Seeker “buy” signal. I then used Barchart’s Flipcharts feature to review the charts for consistent price appreciation. INSM checks those boxes. Since the Trend Seeker signaled a new “Buy” on Oct. 1, the stock has gained 10.12%.

INSM Price vs. Daily Moving Averages:

www.barchart.com

Editor’s Note: The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.

INSM hit a 20-year high of $162.80 in morning trading on Oct. 8.

INSM has a Weighted Alpha of +126.78.

Insmed has an 100% “Buy” opinion from Barchart.

The stock gained 127.29% over the past year.

Insmed has its Trend Seeker “Buy” signal intact.

INSM has made 6 new highs and gained 10.59% in the last month.

Relative Strength Index (RSI) is at 76.32.

There’s a technical support level around $158.60.

$34.3 billion market capitalization.

Revenue is projected to grow 29.95% this year and another 124.91% next year.

Earnings are estimated to increase by 0.62% this year and an additional 34.92% next year.

Story Continues

I don’t buy stocks because everyone else is buying, but I do realize that if major firms and investors are dumping stock, it’s hard to make money swimming against the tide.

It looks like Wall Street analysts have positive opinions on INSM, but Value Line is very cautious.

The Wall Street analysts tracked by Barchart have issued 17 “Strong Buy,” 1 “Moderate Buy” and 2 “Hold” opinions on the stock with price targets between $138 and $240, a very wide range.

Value Line gives the stock its “Lowest” rating with a price target of $162.

CFRA’s MarketScope Advisor rates it a “Hold.”

Morningstar thinks the stock is 30% overvalued.

352 investors following the stock on Motley Fool think the stock will beat the market while 108 think it won’t.

1,370 investors monitor the stock on Seeking Alpha, which rates the stock a “Hold” and comments: “The company’s diversified pipeline, including promising assets like TPIP, reduces reliance on a single product and enhances long-term growth prospects, supported by a substantial cash reserve.”

Analysts project growth in revenue and earnings for Insmed, and the company has a solid following by Wall Street analysts. Investors should note the stock’s volatility and employ disciplined risk management.

Today’s Chart of the Day was written by Jim Van Meerten. Read previous editions of the daily newsletter here.

Additional disclosure: The Barchart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance.

On the date of publication, Jim Van Meerten did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com



Source link

Tags: 20yearBuyhighsstockstrongTrading
ShareTweetShare
Previous Post

Hong Kong’s IPO Boom: Gateway or Risk Trap for Investors?

Next Post

Day Trading Rule #4 – Choosing Your (Trading) Religion

Related Posts

edit post
AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

by TheAdviserMagazine
October 30, 2025
0

Hello and welcome to Eye on AI. In this edition…Nvidia becomes the first $5 trillion market cap company…Anthropic finds AI...

edit post
AI capex boosts from tech giants should benefit Credo, Micron, others: BNP Baripas

AI capex boosts from tech giants should benefit Credo, Micron, others: BNP Baripas

by TheAdviserMagazine
October 30, 2025
0

Oct. 30, 2025 12:03 PM ETMicrosoft Corporation (MSFT) Stock, GOOG Stock, GOOGL Stock, META StockCIEN, AMD, STX, WDC, NVDA, CLS,...

edit post
The uncomfortable secret of successful people: Forget work-life balance, you have to be ‘obsessed’, ex-Wall Streeter and business coach says

The uncomfortable secret of successful people: Forget work-life balance, you have to be ‘obsessed’, ex-Wall Streeter and business coach says

by TheAdviserMagazine
October 30, 2025
0

While casual side hustles can sometimes pay off, the most successful people prioritize their passion to turn it into profit. ...

edit post
Motilal Oswal Q2 Results: PAT plunges 68% YoY to Rs 362 crore, but posts record operating profit

Motilal Oswal Q2 Results: PAT plunges 68% YoY to Rs 362 crore, but posts record operating profit

by TheAdviserMagazine
October 30, 2025
0

Motilal Oswal Financial Services Ltd (MOFSL) reported 68% year-on-year (YoY) decline in its consolidated net profit at Rs 362 crore....

edit post
India to approve deals worth .7b for Israeli defense missiles

India to approve deals worth $3.7b for Israeli defense missiles

by TheAdviserMagazine
October 30, 2025
0

India's Defense Procurement Procedure Administration, headed by Minister of Defense Rajnath Singh, will meet on November 23 to approve...

edit post
Figma acquires Israeli startup Weavy for 0m

Figma acquires Israeli startup Weavy for $200m

by TheAdviserMagazine
October 30, 2025
0

US design software company Figma (NYSE: FIG) has announced the acquisition of Israeli AI powered design workflows company Weavy....

Next Post
edit post
Day Trading Rule #4 – Choosing Your (Trading) Religion

Day Trading Rule #4 - Choosing Your (Trading) Religion

edit post
Flat Tax Revolution: State Income Tax Reform

Flat Tax Revolution: State Income Tax Reform

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Can the IRS Require Personal Information for a Business Tax Debt? – Houston Tax Attorneys

Can the IRS Require Personal Information for a Business Tax Debt? – Houston Tax Attorneys

0
edit post
Fall into Savings: How to Maximize Your 401(k) Before Year-End

Fall into Savings: How to Maximize Your 401(k) Before Year-End

0
edit post
The legal debate over Trump’s Title VI campus crackdown

The legal debate over Trump’s Title VI campus crackdown

0
edit post
Boeing posts Q3 revenue beat, improving cash flow burn rate as CEO Ortberg’s turnaround plan takes off

Boeing posts Q3 revenue beat, improving cash flow burn rate as CEO Ortberg’s turnaround plan takes off

0
edit post
International Agencies Downgrade the U.S. Again, Citing ‘Weakening Governance’ and ‘Fiscal Deterioration.’ Could America’s New Credit Rating Hurt You?

International Agencies Downgrade the U.S. Again, Citing ‘Weakening Governance’ and ‘Fiscal Deterioration.’ Could America’s New Credit Rating Hurt You?

0
edit post
The Top Eight Medical Advancements of the 2010s

The Top Eight Medical Advancements of the 2010s

0
edit post
Ava Labs Transfers BTC.b Infrastructure to Lombard for Multi-Chain Use

Ava Labs Transfers BTC.b Infrastructure to Lombard for Multi-Chain Use

October 30, 2025
edit post
6 Reasons There Are So Many Tiny Homes For Sale

6 Reasons There Are So Many Tiny Homes For Sale

October 30, 2025
edit post
Market Talk – October 30, 2025

Market Talk – October 30, 2025

October 30, 2025
edit post
AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

AI bubble talk grips the market. But in the C-suite there’s more FOMO over AI’s benefits than fear of an AI bustup

October 30, 2025
edit post
Powell forced to stave off uprisings in markets and on his own Fed board as his term ends

Powell forced to stave off uprisings in markets and on his own Fed board as his term ends

October 30, 2025
edit post
International Agencies Downgrade the U.S. Again, Citing ‘Weakening Governance’ and ‘Fiscal Deterioration.’ Could America’s New Credit Rating Hurt You?

International Agencies Downgrade the U.S. Again, Citing ‘Weakening Governance’ and ‘Fiscal Deterioration.’ Could America’s New Credit Rating Hurt You?

October 30, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Ava Labs Transfers BTC.b Infrastructure to Lombard for Multi-Chain Use
  • 6 Reasons There Are So Many Tiny Homes For Sale
  • Market Talk – October 30, 2025
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.